ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis
Gynecologic Oncology
◽
10.1016/j.ygyno.2018.05.001
◽
2018
◽
Vol 150
(1)
◽
pp. 23-30
◽
Cited By ~ 25
Author(s):
Clemens B. Tempfer
◽
Urs Giger-Pabst
◽
Veronika Seebacher
◽
Miriam Petersen
◽
Askin Dogan
◽
...
Keyword(s):
Ovarian Cancer
◽
Phase I
◽
Peritoneal Carcinomatosis
◽
Dose Escalation
◽
Recurrent Ovarian Cancer
◽
Open Label
◽
Dose Escalation Study
◽
Label Dose
Download Full-text
Related Documents
Cited By
References
A Phase IB open-label, dose-escalation study of NUC‑1031 in combination with carboplatin for recurrent ovarian cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-20-4403
◽
2021
◽
pp. clincanres.4403.2020
Author(s):
Farasat Kazmi
◽
Shibani Nicum
◽
Rene L Roux
◽
Laura Spiers
◽
Chat Gnanaranjan
◽
...
Keyword(s):
Ovarian Cancer
◽
Dose Escalation
◽
Recurrent Ovarian Cancer
◽
Open Label
◽
Dose Escalation Study
◽
Phase Ib
◽
Label Dose
Download Full-text
Abstract 1752: A phase I/IIa, first time in human, open-label dose-escalation study of GSK2636771 in subjects with advanced solid tumors with PTEN deficiency
10.1158/1538-7445.am2012-1752
◽
2012
◽
Cited By ~ 4
Author(s):
Samuel C. Blackman
◽
Shelby D. Gainer
◽
Benjamin B. Suttle
◽
Konstantine W. Skordos
◽
Joel D. Greshock
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Open Label
◽
Dose Escalation Study
◽
Label Dose
◽
First Time
Download Full-text
A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status
Cancer Medicine
◽
10.1002/cam4.1140
◽
2017
◽
Vol 6
(8)
◽
pp. 1904-1914
◽
Cited By ~ 11
Author(s):
Benjamin Izar
◽
William Sharfman
◽
F. Stephen Hodi
◽
Donald Lawrence
◽
Keith T. Flaherty
◽
...
Keyword(s):
Phase I
◽
Metastatic Melanoma
◽
Dose Escalation
◽
Braf Mutation
◽
Locally Advanced
◽
Open Label
◽
Dose Escalation Study
◽
Mutation Status
◽
Label Dose
Download Full-text
Combination of CpG7909 and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL): A phase I, open label dose-escalation study of safety and tolerability
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.6594
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 6594-6594
Author(s):
G. J. Weiner
◽
B. K. Link
◽
J. Leonard
◽
C. Emmanouilides
◽
G. Albert
◽
...
Keyword(s):
Phase I
◽
B Cell
◽
Dose Escalation
◽
Hodgkin’S Lymphoma
◽
Hodgkin's Lymphoma
◽
Open Label
◽
Dose Escalation Study
◽
Non Hodgkin’S Lymphoma
◽
Non Hodgkin's Lymphoma
◽
Label Dose
Download Full-text
Phase I, open-label, dose-escalation study of AZD7762 in combination with irinotecan (irino) in patients (pts) with advanced solid tumors.
Journal of Clinical Oncology
◽
10.1200/jco.2011.29.15_suppl.3033
◽
2011
◽
Vol 29
(15_suppl)
◽
pp. 3033-3033
◽
Cited By ~ 19
Author(s):
A. L. Ho
◽
J. C. Bendell
◽
J. M. Cleary
◽
G. K. Schwartz
◽
H. A. Burris
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Open Label
◽
Dose Escalation Study
◽
Label Dose
Download Full-text
Abstract CT038: A phase I, open-label, dose-escalation study to investigate the safety, pharmacokinetics, pharmacodynamics, and clinical activity of GSK3326595 in subjects with solid tumors and non-Hodgkin's lymphoma
10.1158/1538-7445.am2017-ct038
◽
2017
◽
Cited By ~ 2
Author(s):
Drew Rasco
◽
Anthony Tolcher
◽
Lillian L. Siu
◽
Kimberley Heinhuis
◽
Sophie Postel-Vinay
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Hodgkin’S Lymphoma
◽
Hodgkin's Lymphoma
◽
Clinical Activity
◽
Open Label
◽
Dose Escalation Study
◽
Non Hodgkin's Lymphoma
◽
Label Dose
Download Full-text
A Phase I, first-in-human, open label, dose escalation study of MGD007, a humanized gpA33 × CD3 dual-affinity re-targeting (DART®) protein in patients with relapsed/refractory metastatic colorectal carcinoma
Journal for ImmunoTherapy of Cancer
◽
10.1186/2051-1426-2-s3-p86
◽
2014
◽
Vol 2
(Suppl 3)
◽
pp. P86
◽
Cited By ~ 7
Author(s):
Herbert Hurwitz
◽
Todd Crocenzi
◽
Joanna Lohr
◽
Ezio Bonvini
◽
Syd Johnson
◽
...
Keyword(s):
Colorectal Carcinoma
◽
Phase I
◽
Dose Escalation
◽
Metastatic Colorectal Carcinoma
◽
Open Label
◽
Dose Escalation Study
◽
Label Dose
Download Full-text
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer
BMC Cancer
◽
10.1186/s12885-017-3641-6
◽
2017
◽
Vol 17
(1)
◽
Cited By ~ 8
Author(s):
Kerry Lynn Reynolds
◽
Philippe L. Bedard
◽
Se-Hoon Lee
◽
Chia-Chi Lin
◽
Josep Tabernero
◽
...
Keyword(s):
Gastric Cancer
◽
Monoclonal Antibody
◽
Squamous Cell Carcinoma
◽
Phase I
◽
Dose Escalation
◽
Advanced Squamous Cell Carcinoma
◽
Open Label
◽
Dose Escalation Study
◽
Carcinoma Of The Esophagus
◽
Label Dose
Download Full-text
Phase I, open-label, dose-escalation study of SNX-5422 plus everolimus in neuroendocrine tumors (NETs)
Annals of Oncology
◽
10.1093/annonc/mdw369.08
◽
2016
◽
Vol 27
◽
pp. vi138
Author(s):
M.E. Gutierrez
◽
G. Giaccone
◽
S.V. Liu
◽
A. Rajan
◽
U. Guha
◽
...
Keyword(s):
Phase I
◽
Neuroendocrine Tumors
◽
Dose Escalation
◽
Open Label
◽
Dose Escalation Study
◽
Label Dose
Download Full-text
A Phase I, open-label, dose-escalation study of continuous once-daily oral treatment with afatinib in patients with advanced solid tumors
Investigational New Drugs
◽
10.1007/s10637-012-9904-9
◽
2012
◽
Vol 31
(2)
◽
pp. 409-416
◽
Cited By ~ 28
Author(s):
Michael S. Gordon
◽
David S. Mendelson
◽
Mitchell Gross
◽
Martina Uttenreuther-Fischer
◽
Mahmoud Ould-Kaci
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Oral Treatment
◽
Advanced Solid Tumors
◽
Open Label
◽
Dose Escalation Study
◽
Once Daily
◽
Label Dose
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close